缺乏5-HT2A受体的皮层神经元仍可发生致幻剂诱导的神经可塑性
经典致幻剂通过诱导前额叶皮层神经元持久神经可塑性发挥抗抑郁疗效,传统认为需突触后5-HT2A受体。本研究在缺乏突触后5-HT2A受体的颗粒性压后皮层(RSG)中发现,致幻剂仍能诱导持久突触增强,且依赖前丘脑轴突输入上的突触前5-HT2A受体。提示致幻剂治疗潜力可能超出当前认知,或可增强RSG环路功能。
要点
- RSG锥体细胞缺乏突触后5-HT2A受体仍可发生致幻剂诱导的持久突触增强
- 该可塑性依赖前丘脑轴突输入上的突触前5-HT2A受体
- 提示致幻剂或可改善阿尔茨海默病、PTSD等RSG环路受损疾病
核心结论
- 缺乏突触后5-HT2A受体的RSG锥体细胞仍可发生致幻剂诱导的持久突触增强。
- 该可塑性依赖前丘脑轴突输入上表达的突触前5-HT2A受体。
- 致幻剂治疗潜力可能比当前认知更广,或可增强RSG环路功能。
研究设计与样本
- 研究使用新构建的基于CRISPR-Cas的条件性敲除小鼠品系。
- 研究对象为颗粒性压后皮层(RSG)锥体细胞及前丘脑轴突输入。
主要发现
- RSG锥体细胞缺乏突触后5-HT2A受体仍发生致幻剂诱导的持久突触增强。
- 该可塑性需要前丘脑轴突输入上的突触前5-HT2A受体。
关键数值与推荐
- RSG缺乏5-HT2A受体,传统被认为不太可能从致幻剂治疗中获益。
- 条件性敲除小鼠揭示突触前5-HT2A受体是RSG可塑性的必要条件。
临床怎么用
- 提示致幻剂或可拓展用于RSG环路功能受损的神经精神疾病。
- 为阿尔茨海默病、创伤后应激障碍等疾病的致幻剂治疗研究提供机制依据。
局限性
- 证据来自条件性敲除小鼠,尚未在人体或临床样本中验证。
- 原文未报告具体样本量、效应值及统计学细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Classical psychedelic drugs show promise as a treatment for major depressive disorder and related psychiatric disorders. This therapeutic efficacy stems from long-lasting psychedelic-induced neuroplasticity onto prefrontal cortical neurons and is thought to require the postsynaptic expression of serotonin 2A receptors (5-HT2AR). However, other cortical regions such as the granular retrosplenial cortex (RSG) - important for memory, spatial orientation, fear extinction, and imagining oneself in the future, but impaired in Alzheimer's disease - lack 5-HT2AR and are thus considered unlikely to benefit from psychedelic therapy. Here, we show that RSG pyramidal cells lacking postsynaptic 5-HT2A receptors still undergo long-lasting psychedelic-induced synaptic enhancement. A newly engineered CRISPR-Cas-based conditional knockout mouse line reveals that this form of psychedelic-induced retrosplenial plasticity requires presynaptic 5-HT2A receptors expressed on anterior thalamic axonal inputs to RSG. These results highlight a broader psychedelic therapeutic utility than currently appreciated, suggesting potential for augmenting RSG circuit function in Alzheimer's disease, post-traumatic stress disorder, and other neuropsychiatric conditions, despite the lack of postsynaptic 5-HT2A receptors.
引用
- Ekins TG, Rybicki-Kler C, Deng T, et al. Psychedelic neuroplasticity of cortical neurons lacking 5-HT2A receptors. Mol Psychiatry. 2025. PMID: 40957902. doi:10.1038/s41380-025-03257-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。